We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Exceeds Market Returns: Some Facts to Consider
Read MoreHide Full Article
Albemarle (ALB - Free Report) closed at $79.49 in the latest trading session, marking a +1.26% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 1.08%. Elsewhere, the Dow saw an upswing of 0.92%, while the tech-heavy Nasdaq appreciated by 1.41%.
Heading into today, shares of the specialty chemicals company had lost 6.08% over the past month, lagging the Basic Materials sector's loss of 1.64% and outpacing the S&P 500's loss of 8.26% in that time.
Investors will be eagerly watching for the performance of Albemarle in its upcoming earnings disclosure. In that report, analysts expect Albemarle to post earnings of -$0.37 per share. This would mark a year-over-year decline of 242.31%. Meanwhile, our latest consensus estimate is calling for revenue of $1.2 billion, down 11.86% from the prior-year quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.04 per share and revenue of $5.13 billion. These totals would mark changes of +98.29% and -4.55%, respectively, from last year.
Investors should also note any recent changes to analyst estimates for Albemarle. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 110.19% lower. Currently, Albemarle is carrying a Zacks Rank of #3 (Hold).
The Chemical - Diversified industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 206, putting it in the bottom 18% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Albemarle (ALB) Exceeds Market Returns: Some Facts to Consider
Albemarle (ALB - Free Report) closed at $79.49 in the latest trading session, marking a +1.26% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 1.08%. Elsewhere, the Dow saw an upswing of 0.92%, while the tech-heavy Nasdaq appreciated by 1.41%.
Heading into today, shares of the specialty chemicals company had lost 6.08% over the past month, lagging the Basic Materials sector's loss of 1.64% and outpacing the S&P 500's loss of 8.26% in that time.
Investors will be eagerly watching for the performance of Albemarle in its upcoming earnings disclosure. In that report, analysts expect Albemarle to post earnings of -$0.37 per share. This would mark a year-over-year decline of 242.31%. Meanwhile, our latest consensus estimate is calling for revenue of $1.2 billion, down 11.86% from the prior-year quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.04 per share and revenue of $5.13 billion. These totals would mark changes of +98.29% and -4.55%, respectively, from last year.
Investors should also note any recent changes to analyst estimates for Albemarle. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 110.19% lower. Currently, Albemarle is carrying a Zacks Rank of #3 (Hold).
The Chemical - Diversified industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 206, putting it in the bottom 18% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.